Yale-BioHaven Entrepreneurship Seminar: 454 Life Sciences aiming for the $10K Human Genome

October 16, 2006

New Haven, Conn. -- The Yale BioHaven Entrepreneurship Seminar series focuses on 454 Life Sciences on Wednesday, November 8 from 3:30 to 5 p.m. in the Anlyan Center Auditorium of Yale Medical School, 300 Cedar Street.

The speaker will be Christopher McLeod, President and CEO of 454 Life Sciences, established in 2000 as a technology development subsidiary of the Branford, Conn.-based biotechnology company CuraGen Corporation. 454 Life Sciences develops and commercializes novel instrumentation and technology for conducting high-throughput nucleotide sequencing, with specific application to whole-genome sequencing and ultra-deep sequencing of target genes.

The hallmarks of 454 SequencingTM are that it has simple, unbiased sample preparation and high capacity for parallel sequencing. This technology has dramatically increased the feasibility and lowered the cost of large-scale sequencing projects such as the initiative to analyze an individual human genome for $10,000.

The 454 Life Sciences instrumentation, the Genome Sequencer 20TM System, allows one individual to prepare and sequence an entire genome after performing a single sample preparation -- no matter the size of the genome studied. A single instrument using patented light emitting sequencing chemistries produces sequence information at more than 60-times the capacity of instruments using the current technology.

In 2005, the company entered into an agreement with Roche for the promotion, sale, and distribution of 454 Life Sciences' sequencing systems, including proprietary kits and reagents. 454 SequencingTM is being used today by the Max Planck Institute to reconstruct the genome of the Neandertal man, the Dana-Farber Cancer Institute and Broad Institute to detect cancer gene mutations, and the International Census of Marine Microbes to study microbial life in the world's oceans and its impact on our ecosystems.

Refreshments and networking follow the seminar from 5 to 7 p.m. Registration is free, but advance RSVP to Larry Banks at larry.banks@yale.edu or the Yale Office of Cooperative Research at 203-436-8096 is required. Directions to the event are available online at http://info.med.yale.edu/maps/cab.html
-end-
Yale BioHaven Entrepreneurship Seminars are sponsored by the Yale Office of Cooperative Research and Connecticut United for Research Excellence (CURE), and jointly promoted by Yale Entrepreneurial Society (YES) and Yale Biotechnology & Pharmaceutical Society (YBPS). For further information on the seminar, please contact Tracy Huang at 203-785-3846 or tracy.huang@yale.edu .

Yale Office of Cooperative Research - http://www.yale.edu/ocr

Connecticut United for Research Excellence - http://www.curenet.org/

Yale Entrepreneurial Society - http://www.yes.yale.edu/

Yale Biotechnology & Pharmaceutical Society - http://www.yale.edu/ybps

Yale University

Related Genome Articles from Brightsurf:

Genome evolution goes digital
Dr. Alan Herbert from InsideOutBio describes ground-breaking research in a paper published online by Royal Society Open Science.

Breakthrough in genome visualization
Kadir Dede and Dr. Enno Ohlebusch at Ulm University in Germany have devised a method for constructing pan-genome subgraphs at different granularities without having to wait hours and days on end for the software to process the entire genome.

Sturgeon genome sequenced
Sturgeons lived on earth already 300 million years ago and yet their external appearance seems to have undergone very little change.

A sea monster's genome
The giant squid is an elusive giant, but its secrets are about to be revealed.

Deciphering the walnut genome
New research could provide a major boost to the state's growing $1.6 billion walnut industry by making it easier to breed walnut trees better equipped to combat the soil-borne pathogens that now plague many of California's 4,800 growers.

Illuminating the genome
Development of a new molecular visualisation method, RNA-guided endonuclease -- in situ labelling (RGEN-ISL) for the CRISPR/Cas9-mediated labelling of genomic sequences in nuclei and chromosomes.

A genome under influence
References form the basis of our comprehension of the world: they enable us to measure the height of our children or the efficiency of a drug.

How a virus destabilizes the genome
New insights into how Kaposi's sarcoma-associated herpesvirus (KSHV) induces genome instability and promotes cell proliferation could lead to the development of novel antiviral therapies for KSHV-associated cancers, according to a study published Sept.

Better genome editing
Reich Group researchers develop a more efficient and precise method of in-cell genome editing.

Unlocking the genome
A team led by Prof. Stein Aerts (VIB-KU Leuven) uncovers how access to relevant DNA regions is orchestrated in epithelial cells.

Read More: Genome News and Genome Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.